REMICADE®
(infliximab)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
REMICADE® (infliximab)
Medical Information
REMICADE - Density of Reconstituted Solution
Last Updated: 10/15/2024
Summary
For complete information on the preparation and administration of REMICADE, please refer to the full Prescribing Information (PI). As stated in the REMICADE PI, the supplied lyophilized powder must be reconstituted and diluted prior to administration. Reconstitute each 100 mg REMICADE vial with 10 mL of Sterile Water for Injection, USP, to obtain a concentration of 10 mg/mL.1 - The density of REMICADE reconstituted solution is 1.02 g/mL.2
References
| 1 | REMICADE® (infliximab) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/REMICADE-pi.pdf. |
| 2 |